Literature DB >> 7051414

Plasma 6-keto-prostaglandin F1alpha: fact or fiction.

M Greaves, F E Preston.   

Abstract

A radioimmunoassay for 6-keto-prostaglandin F1alpha was developed and validated. The apparent concentration of 6-keto-prostaglandin F1alpha in human venous plasma was found to be less than 50 pg/m1. A rise in plasma 6-keto-prostaglandin F1alpha was detected on infusion of prostacyclin or of DDAVP in human subjects. Various methods of organic extraction were applied to plasma samples prior to radioimmunoassay. Organic extraction and silicic acid chromatography introduced marked and unacceptable nonspecific interference on subsequent radioimmunoassay. This interference was abolished by high pressure liquid chromatography of eluates and extracts prior to assay. Using these methods, a very low concentration of 6-ketoprostaglandin F1alpha in human venous plasma was confirmed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051414     DOI: 10.1016/0049-3848(82)90135-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Abnormalities of vascular prostaglandins in Henoch-Schönlein purpura.

Authors:  S Turi; J J Belch; T J Beattie; C D Forbes
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

2.  Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha.

Authors:  E Vinge; T Corell; K E Andersson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Plasma 6-keto-PGF1 alpha, thromboxane B2 and PGE2 in type 1 (insulin-dependent) diabetic patients during exercise.

Authors:  T Mourits-Andersen; I W Jensen; P N Jensen; J Ditzel; J Dyerberg
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

4.  Effect of vasoactive peptides on prostacyclin synthesis in man.

Authors:  S E Barrow; C T Dollery; D J Heavey; N E Hickling; J M Ritter; J Vial
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

5.  Thromboxane and prostacyclin release in adult respiratory distress syndrome.

Authors:  G Deby-Dupont; M Braun; M Lamy; C Deby; J Pincemail; M E Faymonville; P Damas; L Bodson; M P Lecart; R Goutier
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

6.  Prostacyclin (PGI2).

Authors:  S C Davies; S J Machin
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.